Ignite Creation Date:
2024-05-05 @ 11:36 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00085839
Status:
COMPLETED
Last Update Posted:
2012-08-09
First Post:
2004-06-15
Brief Title:
Erlotinib vs Standard Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer NSCLC and Eastern Cooperative Oncology Group ECOGPerformance Status PS 2
Sponsor:
OSI Pharmaceuticals
Organization:
Astellas Pharma Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-02
Start Date Type:
None
Primary Completion Date:
2007-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2007-03
Completion Date Type:
ACTUAL
First Submit Date:
2004-06-15
First Submit QC Date:
June 16 2004
Study First Post Date:
2004-06-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2011-04-22
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-06
Last Update Post Date:
2012-08-09
Last Update Post Date Type:
ESTIMATED